2014: Re-evaluating the Significant of HPV DNA Test as a Primary Screening Test for Cervical Cancer.

Georgios Papanikolaou must be shock to hear this. The routine Pap Smear Test that he invented in 1928 will no longer play a crucial role in screening for cervical cancer. Early this year, U.S. Food and Drug Administration (FDA) panel of 13 members has voted unanimously to replace the conventional Pap Smear test with a new advanced Human Papillomavirus (HPV) DNA test as the standard acheter du cialis en ligne of care for American women.

The 13-0 votes-by a committee mainly of academic pathologists, microbiologists and gynecologists said that HPV Test is a vital test to detect the genetic material (DNA) of the virus in a sample of cells from the cervix and help identify women who may be at risk of cervical cancer. The advisory committee also recommended that the age for women to be offered an HPV Test be lowered from 30 to 25 years old.

The FDA is an agency of the U.S. Department of Health and Human Services who is responsible for approving laboratory tests before they can be marketed in the U.S. The agency often follows the advice of its advisory committee members- most of them are experts in the field of academic health centers, industry, community practice, and consumer advocates.

Most Cervical Cancers are caused by HPV, a sexually transmitted infection, in particular HPV strains 16 and 18. In Malaysia, Cervical Cancer is the 3rd most frequent cancer among women. About 50% of the cases were diagnosed between the ages of 35 and 55, which are the most economically productive years for women.

In Pantai Premier Pathology, the test simultaneously screens for not only HPV 16 and HPV 18, but also 12 other HPV strains that put women at high risk for Cervical Cancer. Contact us now for more info.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *